Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Depreciation & Amortization (CF) (2020)

Historic Depreciation & Amortization (CF) for Journey Medical (DERM) over the last 1 years, with Q4 2020 value amounting to $1000.0.

  • Journey Medical's Depreciation & Amortization (CF) changed N/A to $1000.0 in Q4 2020 from the same period last year, while for Sep 2021 it was $1000.0, marking a year-over-year change of. This contributed to the annual value of $5000.0 for FY2020, which is N/A changed from last year.
  • Per Journey Medical's latest filing, its Depreciation & Amortization (CF) stood at $1000.0 for Q4 2020.
  • Journey Medical's 5-year Depreciation & Amortization (CF) high stood at $1000.0 for Q3 2020, and its period low was $1000.0 during Q3 2020.